European Union - English - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sonidegib diphosphate - carcinoma, basal cell - antineoplastic agents - odomzo is indicated for the treatment of adult patients with locally advanced basal cell carcinoma (bcc) who are not amenable to curative surgery or radiation therapy.

Canada - English - Health Canada

sun pharmaceutical industries limited - sonidegib (sonidegib phosphate) - capsule - 200mg - sonidegib (sonidegib phosphate) 200mg - antineoplastic agents